ENGLISH
|
HINDI
APPS
iPhone
|
iPad
|
BlackBerry
|
Android
Nokia
Windows
Network18
Quotes
Quotes
NAVs
News
Messages
People
Notices
Videos
All
FEEDBACK
Facebook
Follow @moneycontrolcom on Twitter
CNBC TV 18
moneycontrol
News
Markets
Mutual Funds
IPO
Commodities
Wealth
Portfolio
Messages
My TV
Tax
Fixed Income
Property
SME
CNBC-TV18
Home
Business
General News
Market Trends
Stocks
Fund News
Personal Finance
Corporate Strategy
Lifestyle
Politics
Legal
Master Your Money
Share
>
Share
Tweet
Share on Tumblr
Avdesh Garg
News »
latest
by relevance
Analysts give hot pharma picks for 2006
Oct 31, 2006 at 18:30
Pharma analysts tell Moneycontrol that cut in excise duty, a liberal new drug policy in April, drugs worth USD 25 billion coming off patent in 2006 and a USD 27 billion CRAMS market by 2010 will augur well for both domestic and MNC pharma companies.
Ranbaxys Q4 earnings: What experts expect?
Jan 13, 2006 at 13:13
Pharma major Ranbaxy is likely to report a 52% drop in its consolidated Q4 net profits at Rs 75.8 crore and an EPS of Rs 2 for this quarter. However, analysts feel that the stock could touch Rs 450 in a year's time.
Experts list safe bets in the pharma sector
Nov 10, 2005 at 19:56
Experts advice investors to be stock specific in the pharma sector. According to them, stocks like Ranbaxy, Dr Reddy's, Biocon are likely to get hit in the coming quarter. They are positive on stocks like Dishman Pharmaceuticals, Nicholas Piramal and Jubilant Organosys
Pharma will outperform the Sensex
Aug 26, 2005 at 16:20
Pharma sector stocks are once again buzzing and analysts believe that the entire sector can overperform the Sensex now that the worst seems over. While picking select stocks as value buys, they discussed with Moneycontrol the reasons for their underperformance, challenges ahead and the outlook for the sector.
Analysts give hot pharma picks for 2006
Oct 31, 2006 at 18:30
Pharma analysts tell Moneycontrol that cut in excise duty, a liberal new drug policy in April, drugs worth USD 25 billion coming off patent in 2006 and a USD 27 billion CRAMS market by 2010 will augur well for both domestic and MNC pharma companies.
Ranbaxys Q4 earnings: What experts expect?
Jan 13, 2006 at 13:13
Pharma major Ranbaxy is likely to report a 52% drop in its consolidated Q4 net profits at Rs 75.8 crore and an EPS of Rs 2 for this quarter. However, analysts feel that the stock could touch Rs 450 in a year's time.
Experts list safe bets in the pharma sector
Nov 10, 2005 at 19:56
Experts advice investors to be stock specific in the pharma sector. According to them, stocks like Ranbaxy, Dr Reddy's, Biocon are likely to get hit in the coming quarter. They are positive on stocks like Dishman Pharmaceuticals, Nicholas Piramal and Jubilant Organosys
Pharma will outperform the Sensex
Aug 26, 2005 at 16:20
Pharma sector stocks are once again buzzing and analysts believe that the entire sector can overperform the Sensex now that the worst seems over. While picking select stocks as value buys, they discussed with Moneycontrol the reasons for their underperformance, challenges ahead and the outlook for the sector.
Photos »
/
Follow moneycontrol.com
Facebook
Twitter
Google Plus
RSS
Wap SMS
SMS
Alert
iPad
iPhone
Blackberry
OVI
Android
Window
/ 
/
/